NASDAQ:AGLE

Aeglea BioTherapeutics News Headlines

$7.40
+0.15 (+2.07 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.14
Now: $7.40
$7.47
50-Day Range
$7.08
MA: $7.73
$8.57
52-Week Range
$4.91
Now: $7.40
$11.38
Volume106,047 shs
Average Volume215,828 shs
Market Capitalization$355.32 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66

Headlines

Aeglea BioTherapeutics (NASDAQ AGLE) News Headlines Today

SourceHeadline
Aeglea BioTherapeutics to Participate in Two Virtual Investor Conferences in April 2021Aeglea BioTherapeutics to Participate in Two Virtual Investor Conferences in April 2021
finance.yahoo.com - April 1 at 5:58 PM
Aeglea BioTherapeutics and Immedica Announce Commercialization Agreement for Pegzilarginase for the Treatment of Arginase 1 Deficiency in Europe and Middle EastAeglea BioTherapeutics and Immedica Announce Commercialization Agreement for Pegzilarginase for the Treatment of Arginase 1 Deficiency in Europe and Middle East
finance.yahoo.com - March 22 at 10:31 AM
Aeglea BioTherapeutics (NASDAQ:AGLE) Releases Quarterly  Earnings Results, Misses Expectations By $0.04 EPSAeglea BioTherapeutics (NASDAQ:AGLE) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS
americanbankingnews.com - March 19 at 8:14 AM
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate HighlightsAeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
finance.yahoo.com - March 18 at 12:34 PM
Aeglea BioTherapeutics Appoints Sara Brownstein to Board of DirectorsAeglea BioTherapeutics Appoints Sara Brownstein to Board of Directors
finance.yahoo.com - February 24 at 5:03 PM
We Think Aeglea BioTherapeutics (NASDAQ:AGLE) Needs To Drive Business Growth CarefullyWe Think Aeglea BioTherapeutics (NASDAQ:AGLE) Needs To Drive Business Growth Carefully
finance.yahoo.com - February 18 at 9:29 AM
AGLE Feb 2021 7.500 callAGLE Feb 2021 7.500 call
ca.finance.yahoo.com - January 23 at 5:00 PM
Aeglea BioTherapeutics to Present at 39th Annual J.P. Morgan Healthcare ConferenceAeglea BioTherapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 4:41 PM
Aeglea (AGLE) Upgraded to Buy: Heres WhyAeglea (AGLE) Upgraded to Buy: Here's Why
finance.yahoo.com - December 30 at 12:55 PM
Is AGLE A Good Stock To Buy Now According To Hedge Funds?Is AGLE A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 19 at 12:41 AM
Aeglea BioTherapeutics Appoints Alison Lawton to Board of DirectorsAeglea BioTherapeutics Appoints Alison Lawton to Board of Directors
finance.yahoo.com - December 17 at 6:36 PM
Aeglea Bios ACN00177 nabs Rare Pediatric status for inherited metabolic disorderAeglea Bio's ACN00177 nabs Rare Pediatric status for inherited metabolic disorder
seekingalpha.com - December 1 at 4:27 PM
Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of HomocystinuriaAeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria
finance.yahoo.com - December 1 at 8:33 AM
Aeglea BioTherapeutics to Participate in Two Upcoming Virtual Investor ConferencesAeglea BioTherapeutics to Participate in Two Upcoming Virtual Investor Conferences
finance.yahoo.com - November 17 at 5:57 PM
How Much Are Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Insiders Spending On Buying Shares?How Much Are Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Insiders Spending On Buying Shares?
finance.yahoo.com - November 10 at 8:26 AM
Aeglea BioTherapeutics Reports Third Quarter 2020 Financial Results and Corporate HighlightsAeglea BioTherapeutics Reports Third Quarter 2020 Financial Results and Corporate Highlights
markets.businessinsider.com - November 5 at 9:12 AM
Is a Surprise Coming for Aeglea (AGLE) This Earnings Season?Is a Surprise Coming for Aeglea (AGLE) This Earnings Season?
finance.yahoo.com - November 3 at 9:50 AM
Aeglea BioTherapeutics Announces U.S. and EU Orphan Drug Designations for ACN00177 for the Treatment of HomocystinuriaAeglea BioTherapeutics Announces U.S. and EU Orphan Drug Designations for ACN00177 for the Treatment of Homocystinuria
finance.yahoo.com - October 26 at 8:52 AM
Is Aeglea BioTherapeutics (NASDAQ:AGLE) In A Good Position To Invest In Growth?Is Aeglea BioTherapeutics (NASDAQ:AGLE) In A Good Position To Invest In Growth?
finance.yahoo.com - September 11 at 7:31 AM
Aeglea BioTherapeutics to Participate in September Investment ConferencesAeglea BioTherapeutics to Participate in September Investment Conferences
finance.yahoo.com - September 2 at 5:40 PM
Aeglea (AGLE) Looks Good: Stock Adds 5.8% in SessionAeglea (AGLE) Looks Good: Stock Adds 5.8% in Session
finance.yahoo.com - August 25 at 1:51 PM
Aeglea BioTherapeutics to Present at World Orphan Drug Congress USA 2020Aeglea BioTherapeutics to Present at World Orphan Drug Congress USA 2020
finance.yahoo.com - August 18 at 4:37 PM
Aeglea BioTherapeutics Inc.Aeglea BioTherapeutics Inc.
barrons.com - August 14 at 2:34 PM
Aeglea BioTherapeutics Reports Second Quarter 2020 Financial Results and Corporate HighlightsAeglea BioTherapeutics Reports Second Quarter 2020 Financial Results and Corporate Highlights
finance.yahoo.com - August 10 at 9:31 AM
How Should Investors React To Aeglea BioTherapeutics (NASDAQ:AGLE) CEO Pay?How Should Investors React To Aeglea BioTherapeutics' (NASDAQ:AGLE) CEO Pay?
finance.yahoo.com - July 13 at 1:31 PM
How Should Investors React To Aeglea BioTherapeutics' (NASDAQ:AGLE) CEO Pay?How Should Investors React To Aeglea BioTherapeutics' (NASDAQ:AGLE) CEO Pay?
finance.yahoo.com - July 13 at 1:31 PM
BRIEF-Aeglea Bio Therapeutics Inc Files For Mixed Shelf Of Upto $400 MillionBRIEF-Aeglea Bio Therapeutics Inc Files For Mixed Shelf Of Upto $400 Million
uk.reuters.com - July 6 at 11:36 PM
Heres Why Momentum Investors Will Love Aeglea Biotherapeutics (AGLE)Here's Why Momentum Investors Will Love Aeglea Biotherapeutics (AGLE)
www.nasdaq.com - June 29 at 5:43 PM
Here's Why Momentum Investors Will Love Aeglea Biotherapeutics (AGLE)Here's Why Momentum Investors Will Love Aeglea Biotherapeutics (AGLE)
finance.yahoo.com - June 29 at 12:43 PM
Aeglea BioTherapeutics (AGLE) Catches Eye: Stock Jumps 5.1%Aeglea BioTherapeutics (AGLE) Catches Eye: Stock Jumps 5.1%
finance.yahoo.com - June 23 at 12:17 PM
Has Aeglea BioTherapeutics (AGLE) Outpaced Other Medical Stocks This Year?Has Aeglea BioTherapeutics (AGLE) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - June 10 at 1:34 PM
Why Aeglea BioTherapeutics (AGLE) Stock Might be a Great PickWhy Aeglea BioTherapeutics (AGLE) Stock Might be a Great Pick
finance.yahoo.com - June 8 at 1:47 PM
Aeglea BioTherapeutics to Present at BIO Digital 2020Aeglea BioTherapeutics to Present at BIO Digital 2020
finance.yahoo.com - June 1 at 5:33 PM
Aeglea BioTherapeutics Shares March Higher, Can It Continue?Aeglea BioTherapeutics' Shares March Higher, Can It Continue?
finance.yahoo.com - May 29 at 2:43 PM
Aeglea BioTherapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held June 8, 2020Aeglea BioTherapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held June 8, 2020
finance.yahoo.com - May 28 at 6:21 PM
Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1%Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1%
finance.yahoo.com - May 27 at 12:05 PM
Aeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of NeurologyAeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology
finance.yahoo.com - May 26 at 11:01 AM
Is Aeglea BioTherapeutics (AGLE) Outperforming Other Medical Stocks This Year?Is Aeglea BioTherapeutics (AGLE) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 21 at 1:29 PM
Zacks.com featured highlights include: Aeglea BioTherapeutics, VeriSign, Sequans Communications and New Jersey ResourcesZacks.com featured highlights include: Aeglea BioTherapeutics, VeriSign, Sequans Communications and New Jersey Resources
finance.yahoo.com - May 20 at 9:49 AM
Find Strong Stocks During the Coronavirus with New Analyst CoverageFind Strong Stocks During the Coronavirus with New Analyst Coverage
finance.yahoo.com - May 20 at 4:29 AM
Aeglea BioTherapeutics Reports First Quarter 2020 Financial Results and Corporate HighlightsAeglea BioTherapeutics Reports First Quarter 2020 Financial Results and Corporate Highlights
finance.yahoo.com - May 7 at 1:56 PM
Is Aeglea BioTherapeutics (AGLE) Stock a Solid Choice Right Now?Is Aeglea BioTherapeutics (AGLE) Stock a Solid Choice Right Now?
finance.yahoo.com - May 7 at 1:56 PM
Aeglea BioTherapeutics, Inc. (AGLE) Shares March Higher, Can It Continue?Aeglea BioTherapeutics, Inc. (AGLE) Shares March Higher, Can It Continue?
finance.yahoo.com - May 6 at 11:35 AM
Anthony Quinn Is The President of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) And They Just Picked Up 44% More SharesAnthony Quinn Is The President of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) And They Just Picked Up 44% More Shares
finance.yahoo.com - May 6 at 6:30 AM
Aeglea (AGLE) Upgraded to Strong Buy: What Does It Mean for the Stock?Aeglea (AGLE) Upgraded to Strong Buy: What Does It Mean for the Stock?
finance.yahoo.com - May 5 at 3:29 PM
Aeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesAeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
www.marketwatch.com - April 30 at 9:05 PM
Aeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesAeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 30 at 9:05 PM
Stock Alert: Aeglea BioTherapeutics Up 18%Stock Alert: Aeglea BioTherapeutics Up 18%
www.nasdaq.com - April 28 at 11:13 AM
Aeglea BioTherapeutics Announces Pricing of $120 Million Public OfferingAeglea BioTherapeutics Announces Pricing of $120 Million Public Offering
finance.yahoo.com - April 28 at 11:13 AM
Aeglea BioTherapeutics Announces Proposed Public OfferingAeglea BioTherapeutics Announces Proposed Public Offering
finance.yahoo.com - April 27 at 6:43 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.